Clinical characteristics and long-term prognosis of female patients with acute coronary syndrome.

acute coronary syndrome cardiovascular diseases health equity prognosis women’s health

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2024
Historique:
received: 11 06 2024
accepted: 26 07 2024
medline: 9 9 2024
pubmed: 9 9 2024
entrez: 9 9 2024
Statut: epublish

Résumé

Cardiovascular disease has traditionally been studied predominantly in men, but understanding its manifestations in women is crucial for effective management. This study aims to evaluate the long-term prognosis of female patients with acute coronary syndrome (ACS) within a tertiary hospital setting in Spain. Retrospective observational study based on a cohort of consecutive hospitalized patients with ACS from January 2009 to December 2014. Data on demographics, risk factors, treatment, and outcomes were collected, with a median follow-up of 9.2 years. Women with ACS, constituting 27.3% of 2,330 patients, were older and had a higher prevalence of cardiovascular risk factors such as obesity, hypertension, and diabetes mellitus compared to men. They presented with more non-ST-segment elevation myocardial infarction and underwent less coronary angiography. Female patients were also less likely to be treated with acetylsalicylic acid, a second antiplatelet drug, or statins. Despite initial higher mortality rates [hazard ratio (HR) 1.30; 95% confidence interval (CI) 1.13-1.49; Women with ACS are more comorbid, but after adjustments, female sex appears to be a protective factor that confers a better long-term prognosis.

Sections du résumé

Background UNASSIGNED
Cardiovascular disease has traditionally been studied predominantly in men, but understanding its manifestations in women is crucial for effective management. This study aims to evaluate the long-term prognosis of female patients with acute coronary syndrome (ACS) within a tertiary hospital setting in Spain.
Methods UNASSIGNED
Retrospective observational study based on a cohort of consecutive hospitalized patients with ACS from January 2009 to December 2014. Data on demographics, risk factors, treatment, and outcomes were collected, with a median follow-up of 9.2 years.
Results UNASSIGNED
Women with ACS, constituting 27.3% of 2,330 patients, were older and had a higher prevalence of cardiovascular risk factors such as obesity, hypertension, and diabetes mellitus compared to men. They presented with more non-ST-segment elevation myocardial infarction and underwent less coronary angiography. Female patients were also less likely to be treated with acetylsalicylic acid, a second antiplatelet drug, or statins. Despite initial higher mortality rates [hazard ratio (HR) 1.30; 95% confidence interval (CI) 1.13-1.49;
Conclusions UNASSIGNED
Women with ACS are more comorbid, but after adjustments, female sex appears to be a protective factor that confers a better long-term prognosis.

Identifiants

pubmed: 39246582
doi: 10.3389/fcvm.2024.1447533
pmc: PMC11377307
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1447533

Informations de copyright

© 2024 Rocamora-Horrach, Peiró, Bardají, Flores-Benítez, Ivorra-Cámara, Carrasquer and Ferreiro.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Mar Rocamora-Horrach (M)

Department of Cardiology, Joan XXIII University Hospital, Tarragona, Spain.
Pere Virgili Health Research Institute, Rovira i Virgili University, Tarragona, Spain.
Department of Medicine and Surgery, Rovira i Virgili University, Tarragona, Spain.

Óscar M Peiró (ÓM)

Department of Cardiology, Joan XXIII University Hospital, Tarragona, Spain.
Pere Virgili Health Research Institute, Rovira i Virgili University, Tarragona, Spain.
Department of Medicine and Surgery, Rovira i Virgili University, Tarragona, Spain.

Alfredo Bardají (A)

Department of Cardiology, Joan XXIII University Hospital, Tarragona, Spain.
Pere Virgili Health Research Institute, Rovira i Virgili University, Tarragona, Spain.
Department of Medicine and Surgery, Rovira i Virgili University, Tarragona, Spain.

Javier Flores-Benítez (J)

Department of Cardiology, Joan XXIII University Hospital, Tarragona, Spain.
Pere Virgili Health Research Institute, Rovira i Virgili University, Tarragona, Spain.

Miguel Ivorra-Cámara (M)

Department of Cardiology, Joan XXIII University Hospital, Tarragona, Spain.
Pere Virgili Health Research Institute, Rovira i Virgili University, Tarragona, Spain.

Anna Carrasquer (A)

Department of Cardiology, Joan XXIII University Hospital, Tarragona, Spain.
Pere Virgili Health Research Institute, Rovira i Virgili University, Tarragona, Spain.
Department of Medicine and Surgery, Rovira i Virgili University, Tarragona, Spain.

José Luis Ferreiro (JL)

Department of Cardiology, Joan XXIII University Hospital, Tarragona, Spain.
Pere Virgili Health Research Institute, Rovira i Virgili University, Tarragona, Spain.
Department of Medicine and Surgery, Rovira i Virgili University, Tarragona, Spain.

Classifications MeSH